Answers are grounded in this paper and cite their sources.
Demonstrates that inhibiting Wnt signaling prevents postnatal inflammation and disease progression in a mouse model of myxomatous valve disease, suggesting a potential therapeutic target.
Myxomatous valve disease (MVD) is the most common cause of mitral regurgitation, leading to impaired cardiac function and heart failure. MVD in a mouse model of Marfan syndrome includes valve leaflet thickening and progressive valve degeneration. However, the underlying mechanisms by which the disease progresses remain undefined.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: